1,270
Views
29
CrossRef citations to date
0
Altmetric
Review Article

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network

, , , , , , , , , , , , , , , , , , , & show all
Pages 699-707 | Received 11 Sep 2012, Accepted 21 Sep 2012, Published online: 21 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Venera Kuci, Lena Nordström, Mats Jerkeman & Sara Ek. (2015) Emerging role of SOX11 in mantle cell lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 5, pages 35-42.
Read now
Niklas Vogt, Dmitriy Abramov, Karoline Koch, Neus Masqué-Soler, Monika Szczepanowski & Wolfram Klapper. (2015) No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo. Leukemia & Lymphoma 56:7, pages 2134-2140.
Read now

Articles from other publishers (27)

Amer Wahed, Andres Quesada & Amitava Dasgupta. 2020. Hematology and Coagulation. Hematology and Coagulation 177 200 .
Ali Sakhdari, Chi Young Ok, Keyur P. Patel, Rashmi Kanagal-Shamanna, C. Cameron Yin, Zhuang Zuo, Shimin Hu, Mark J. Routbort, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Joseph D. Khoury & Sanam Loghavi. (2019) TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant. Annals of Diagnostic Pathology 41, pages 38-42.
Crossref
Yuandong Zhu, Wenxian Xu, Xiao Zheng & Zhuojun Zheng. (2023) Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma. Journal of Investigative Medicine 67:2, pages 331-337.
Crossref
Catja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, Christian Winther Eskelund, Kirsten Grønbæk, Roger Olsson, Fredrik Ek, Mats Jerkeman & Sara Ek. (2018) Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity. BMC Cancer 18:1.
Crossref
Carlo Visco, Annalisa Chiappella, Luca Nassi, Caterina Patti, Simone Ferrero, Daniela Barbero, Andrea Evangelista, Michele Spina, Annalia Molinari, Luigi Rigacci, Monica Tani, Alice Di Rocco, Graziella Pinotti, Alberto Fabbri, Renato Zambello, Silvia Finotto, Manuel Gotti, Angelo M Carella, Flavia Salvi, Stefano A Pileri, Marco Ladetto, Giovannino Ciccone, Gianluca Gaidano, Marco Ruggeri, Maurizio Martelli & Umberto Vitolo. (2017) Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi. The Lancet Haematology 4:1, pages e15-e23.
Crossref
Marjolijn van Keep, Kerry Gairy, Divyagiri Seshagiri, Pushpike Thilakarathne & Dawn Lee. (2016) Cost-effectiveness analysis of bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP) in patients with previously untreated mantle cell lymphoma. BMC Cancer 16:1.
Crossref
Marek Trněný, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Boris Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trümper, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo & Luca Arcaini. (2016) Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial. The Lancet Oncology 17:3, pages 319-331.
Crossref
. 2016. The Cutaneous Lymphoid Proliferations. The Cutaneous Lymphoid Proliferations 225 235 .
Ji-Young Choe, Ji Yun Yun, Hee Young Na, Jooryung Huh, Su-Jin Shin, Hyun-Jung Kim, Jin Ho Paik, Young A Kim, Soo Jeong Nam, Yoon Kyung Jeon, Gyeongsin Park & Ji Eun Kim. (2016) MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma . Histopathology 68:3, pages 442-449.
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology 6-28 6-33 .
Georg Hess, Bertrand Coiffier, Michael Crump, Christian Gisselbrecht, Fritz Offner, Jorge Romaguera, Lisa Kang & Pádraig J Moran. (2015) Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis. Experimental Hematology & Oncology 4:1.
Crossref
Lucie Lorkova, Michaela Scigelova, Tabiwang Ndipanquang Arrey, Ondrej Vit, Jana Pospisilova, Eliska Doktorova, Magdalena Klanova, Mahmudul Alam, Petra Vockova, Bokang Maswabi, Pavel Klener & Jiri Petrak. (2015) Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLOS ONE 10:8, pages e0135314.
Crossref
Peter J. Hosein, Jose D. Sandoval-Sus, Deborah Goodman, Alexandra Gomez Arteaga, Isildinha Reis, James Hoffman, Alexandra Stefanovic, Joseph D. Rosenblatt & Izidore S. Lossos. (2015) Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma. American Journal of Hematology 90:6, pages E111-E116.
Crossref
David Chiron, Christelle Dousset, Carole Brosseau, Cyrille Touzeau, Sophie Maïga, Philippe Moreau, Catherine Pellat-Deceunynck, Steven Le Gouill & Martine Amiot. (2015) Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma. Oncotarget 6:11, pages 8750-8759.
Crossref
Amer Wahed & Amitava Dasgupta. 2015. Hematology and Coagulation. Hematology and Coagulation 177 197 .
Simone Ferrero & Martin Dreyling. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 143 168 .
Magdalena Klanova, Lucie Lorkova, Ondrej Vit, Bokang Maswabi, Jan Molinsky, Jana Pospisilova, Petra Vockova, Cory Mavis, Lucie Lateckova, Vojtech Kulvait, Dana Vejmelkova, Radek Jaksa, Francisco Hernandez, Marek Trneny, Martin Vokurka, Jiri Petrak & Pavel KlenerJrJr. (2014) Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents. Molecular Cancer 13:1.
Crossref
Lina Nygren, Agata M. Wasik, Stefanie Baumgartner-Wennerholm, Åsa Jeppsson-Ahlberg, Monika Klimkowska, Patrik Andersson, Daren Buhrkuhl, Birger Christensson, Eva Kimby, Björn E. Wahlin & Birgitta Sander. (2014) T-Cell Levels Are Prognostic in Mantle Cell Lymphoma. Clinical Cancer Research 20:23, pages 6096-6104.
Crossref
C Brosseau, C Dousset, C Touzeau, S Maïga, P Moreau, M Amiot, S Le Gouill & C Pellat-Deceunynck. (2014) Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. Cell Death & Disease 5:8, pages e1389-e1389.
Crossref
Martin DreylingSimone Ferrero. (2014) How to treat old MCL patients: one size fits it all?. Blood 124:8, pages 1207-1208.
Crossref
Lena Nordström, Sandra Sernbo, Patrik Eden, Kirsten Grønbæk, Arne Kolstad, Riikka Räty, Marja‐Liisa Karjalainen, Christian Geisler, Elisabeth Ralfkiær, Christer Sundström, Anna Laurell, Jan Delabie, Mats Ehinger, Mats Jerkeman & Sara Ek. (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study. British Journal of Haematology 166:1, pages 98-108.
Crossref
Alexander Kanellopoulos, Katrina Koutsi, George Georgiou, Themis Ntalagiorgos, Kyriaki Petevi, George Boutsikas, Loula Papageorgiou, Gabriela Gainaru, Pagona Flevari, Maria K. Angelopoulou, John Meletis & Theodoros P. Vassilakopoulos. (2014) Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma. International Journal of Hematology 99:6, pages 777-781.
Crossref
Erik Magnusson, Qing Cao, Michael A. Linden, Jerry Frolich, Vidhu Anand, Linda J. Burns & Veronika Bachanova. (2014) Hematopoietic Cell Transplantation for Mantle Cell Lymphoma: Predictive Value of Pretransplant Positron Emission Tomography/Computed Tomography and Bone Marrow Evaluations for Outcomes. Clinical Lymphoma Myeloma and Leukemia 14:2, pages 114-121.
Crossref
Nimish Shah & Simon Rule. (2014) Management perspective for mantle cell lymphoma. International Journal of Hematologic Oncology 3:1, pages 31-40.
Crossref
M Meggendorfer, W Kern, C Haferlach, T Haferlach & S Schnittger. (2013) SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis. Leukemia 27:12, pages 2388-2391.
Crossref
Bertrand Coiffier. (2013) Clinical Efficacy and Management of Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 351-359.
Crossref
Giulia Benevolo, Annalisa Chiappella & Umberto Vitolo. (2013) XVI. CNS prophylaxis in aggressive lymphomas: for whom and how. Hematological Oncology 31:S1, pages 89-91.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.